期刊文献+

上尿路梗阻致脓毒性休克的治疗 被引量:5

Treatment of septic shock from upper urinary obstruction
原文传递
导出
摘要 目的探讨上尿路梗阻(UUO)致脓毒性休克(SS)的治疗方法。方法UUO致SS患者72例。采用快速补液、血管活性药物、小剂量糖皮质激素、广谱抗生素及早期肠道营养等常规治疗30例;常规治疗同时加连续性静脉-静脉血液滤过(CVVH)治疗42例。患者生命体征平稳后行外科治疗解除梗阻。比较2组患者ICU治疗前、治疗24h后急性生理学及慢性健康状况评分Ⅱ(APACHEⅡ)、多器官功能障碍综合征(MODS)评分、治疗干预评分系统(TISS)评分、ICU住院时间和病死率。结果常规组与综合组患者治疗前APACHEⅡ评分(22.1±5.9与21.9±6.0)、MODS评分(7.8±4.3与7.8±4.2)比较差异均无统计学意义(P〉0.05)。治疗24h后2组间APACHEII评分(19.7±5.5与14.8±5.2)、MODS评分(7.3±1.4与4.0±1.2)比较差异均有统计学意义(P〈0.05)。2组转出ICU时TISS评分(51.8±17.4与42.3±16.6)、ICU住院时间[(12.6±6.3)d与5.3±2.6)d]和病死率(46.7%与11.9%)比较差异均有统计学意义(P〈0.05)。ICU治疗后综合组患者病情改善率为88.0%(37/42),常规组为53.3%(16/30)。50例具备行外科手术条件者行B超引导下经皮肾穿刺造瘘或经尿道输尿管镜技术解除梗阻,49例手术治疗痊愈,1例死于心脏骤停。2例拒绝手术治疗者分别死于呼吸衰竭及消化道大出血,1例自动出院。结论CVVH结合外科手术解除梗阻治疗UU0致SS,能提高救治成功率。 Objective To investigate the treatment of septic shock(SS) from upper urinary obstruction(UUO). Methods Continuous veno-venous haemofihration(CVVH) combined with surgical method was applied to 42 SS patients from UUO. Their general conditions, liver and kidney functions, APACHE II, therapeutic intervention scorisystem(TISS), multiple organ dysfunction syndrome (MODS), complication rate and main outcomes were analysed comparing with traditional therapies groups(n= 30). Results Compared with those traditional therapies, the APACHE H , MODS and TISS score decreased (P〈0.05). Thirty-seven out of 42 patients survived and the survival rate was 88.0% during ICU. Conclusion CVVH combined with surgical methods may effectively decrease the incidence of complications and mortality of SS from UUO, and the mechanism may be related to the remove of mediators of inflammation.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2010年第8期516-519,共4页 Chinese Journal of Urology
关键词 上尿路梗阻 脓毒性休克 连续性血液滤过 Upper urinary obstruction Septic shock Continuous veno-venous haemofiltration
  • 相关文献

参考文献11

  • 1俞娅芬,陈德昌,宋秀琴.早期诊断严重脓毒症 脓毒性休克研究进展[J].中国急救医学,2007,27(2):154-156. 被引量:56
  • 2Toft P,Nilsen BU,Bollen P,et al.The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia.Acta Anaesthesiol Scand,2007,51:679-686.
  • 3Morrell MR,Micek ST,Kollef MH.The management of severe sepsis and septic shock.Infect Dis Clin North Am,2009,23:485-501.
  • 4Joannidis M.Continuous renal replacement therapy in sepsis and multisystem organ failure.Semin Dial,2009,22:160-164.
  • 5Dellinger RP,Levy MM,Carlet JM,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2008.Intensive Care Med,2008,34:783-785.
  • 6Rudiger A,Stotz M,Singer M,et al.Cellular processes in sepsis.Swiss Med Wkly,2008,138:629-634.
  • 7Gao F,Melody T,Daniels DF,et al.The impact of comp liance with 6 hour and 24 hour sepsis bundles on hospital mortality in patients with severe sep sis:a prospective observational study.Crit Care,2005,9:764-770.
  • 8Li CM,Chen JH,Zhang P,et al.Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock.Anaesthesia and Intensive Care,2007,35:911-919.
  • 9伍民生,周红卫,赵晓琴.连续性血液净化在ICU多脏器功能障碍综合征患者中的应用[J].医学综述,2008,14(2):292-294. 被引量:23
  • 10李笑宏,赵铭山,焦文建,颜卫峰,王春检.连续性血液净化治疗对SIRS、MODS患者免疫功能的影响[J].山东医药,2005,45(34):10-12. 被引量:8

二级参考文献45

  • 1Puppo P, Ricciotti G, Bozzo W, et al. Primary endoscopic treatment of ureteric calcui. A review of 378 cases[J]. Eur Urol, 1999, 36(1): 48-52.
  • 2Bagley D. Use of the holmium laser in the upper urinary tract[J]. Techn Urol, 1995, 1(1): 25-30.
  • 3Ronco C,Inguaggiato P,DIntini V,et al.The role of extracorpo-real therapies in sepsis[J]. J Nephrol,2003,16(suppl 7): 34-41.
  • 4Koch T.Origin and mediators involved in sepsis and the systemic inflammatory response syndrome[J]. Kidney Int,1998,53(suppl 64):66-69.
  • 5American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Deffinition for sepsis and organ failure and guidelines for the use of innovative therapies[J]. Crit Care Med,1992,20(7): 864-865.
  • 6Christ-Crain M,Morgenthaler NG,Struck J,et al.Mid-regional pro-ADM as a prognostic marker in sepsis:an observational study[J].Crit Care,2005,9(6):816 -824.
  • 7Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine[J].Chest,1992,101:1644-1665.
  • 8Emanuel P,Lauralyn McIntyre,David C,et al.Early and innovative inter vention for severe sepsis and septic shock:taking advantage of a window of opportunity[J].CMAJ,2005,10 (25):173-179.
  • 9Karimova A,Pinsky DJ.The endothelial response to oxygen deprivation:biology and clinical implications[J].Intensive Care Med,2001,27:19 -31.
  • 10Reinhart K,Kuhn HJ,Hartog C,et al.Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill[J].Intensive Care Med,2004,30:1572-1578.

共引文献90

同被引文献53

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部